What is the Tarsons Products PE ratio today?
Tarsons Products' PE ratio is 145.8 at the 29 October 2026 close (₹303.95 a share): a market capitalisation of ₹1,617 crore divided by consolidated net profit of ₹11.1 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹14.3 crore) it is 112.9.
What is the Tarsons Products debt to equity ratio?
Tarsons Products' debt-to-equity ratio was 0.60 on 31 March 2026: borrowings of ₹383 crore against total equity of ₹635 crore. A year earlier, on 31 March 2025, it was 0.52.
What is the Tarsons Products net worth?
Tarsons Products' net worth — shareholders' equity in its consolidated balance sheet — was ₹635 crore on 31 March 2026, up 0.7% from ₹630 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹1,617 crore at the 29 October 2026 close.
What is the Tarsons Products PB ratio (price to book value)?
Tarsons Products' price-to-book (PB) ratio is 2.55 at the 29 October 2026 close: a market capitalisation of ₹1,617 crore divided by shareholders' equity (book value) of ₹635 crore on 31 March 2026. That is a book value of ₹119.29 per share against a share price of ₹303.95.
What is the Tarsons Products ROE and ROCE?
In FY26, Tarsons Products' return on equity (ROE) was 2.3% and its return on capital employed (ROCE) was 2.3%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 4.8% and ROCE 5.8%.
What is the Tarsons Products book value per share?
Tarsons Products' book value per share was ₹119.29 on 31 March 2026: shareholders' equity of ₹635 crore divided by the 5.32 crore shares in issue, up 0.7% from ₹118.45 a year earlier. The share price at the 29 October 2026 close was ₹303.95.
What is the Tarsons Products market cap?
Tarsons Products' market capitalisation was ₹1,617 crore at the 29 October 2026 close: 5.32 crore shares at ₹303.95 each.
Is Tarsons Products debt free?
No. Tarsons Products had borrowings of ₹383 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.60. Its cash and current investments were ₹25.3 crore, so its net debt was ₹357 crore.
What is the Tarsons Products EPS?
Tarsons Products' basic earnings per share (EPS) were ₹2.69 in FY26, against ₹5.60 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹2.09.
What is the Tarsons Products promoter holding?
Promoters held 47.30% of Tarsons Products on 30 September 2026, unchanged from the previous quarter and down 0.01 percentage points from 47.31% a year earlier, according to the shareholding pattern filed with NSE.
What is the Tarsons Products free cash flow?
In FY26, Tarsons Products generated ₹118 crore of cash from operations and spent ₹126 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹7.1 crore. In FY25 it was −₹37.5 crore.
When are the Tarsons Products next results?
Tarsons Products has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
What is the Tarsons Products shareholding pattern?
On 30 September 2026, Tarsons Products' shares were held by promoters 47.30%, foreign portfolio investors (FII/FPI) 0.55%, domestic institutions (DII) 0.61% (including mutual funds at 0.00%) and retail and other non-institutional investors 51.53%. Over the year, FII holding was down 5.27 percentage points from 5.82% and DII holding was up 0.53 percentage points from 0.08%.
How does Tarsons Products compare with its peers?
On FY26 consolidated figures, against Fischer Medical Ventures, Laxmi Dental and Fabtech Technologies: Tarsons Products' operating margin of 5.1% is the lowest of the four (Fischer Medical Ventures 13.0%, Laxmi Dental 9.9%, Fabtech Technologies 7.2%; peer average 10.0%); its return on equity of 2.3% is the lowest of the four (Fischer Medical Ventures 8.1%, Laxmi Dental 12.8%, Fabtech Technologies 9.1%; peer average 10.0%).
How does the Tarsons Products PE ratio compare with its peers?
At the 29 October 2026 closing prices, on FY26 net profit, Tarsons Products' PE ratio is 112.9, the highest of the four: Fischer Medical Ventures 54.7, Laxmi Dental 33.6 and Fabtech Technologies 14.2, a peer average of 34.2. Each is the company's market capitalisation at that price divided by its FY26 net profit.
What are the Tarsons Products latest quarterly results?
Tarsons Products' latest results are for Q1 FY27 (April–June 2026), filed on 10 August 2026: consolidated net loss ₹1.4 crore, against a profit of ₹1.8 crore in Q1 FY26; revenue from operations ₹110 crore, up 20.7% year on year.
What is the Tarsons Products revenue and profit in FY26?
In FY26 (April 2025–March 2026), Tarsons Products' consolidated net profit was ₹14.3 crore, down 51.9% from ₹29.8 crore in FY25, on revenue from operations of ₹423 crore (up 7.7%).
Tarsons Products vs Fischer Medical Ventures: how do they compare?
In FY26, Tarsons Products earned net profit of ₹14.3 crore on revenue of ₹423 crore, against ₹31 crore on ₹309 crore for Fischer Medical Ventures. Tarsons Products' operating margin was 5.1% (Fischer Medical Ventures 13.0%) and its return on equity 2.3% (Fischer Medical Ventures 8.1%). At the 29 October 2026 close, Tarsons Products' market capitalisation was ₹1,617 crore against ₹1,697 crore for Fischer Medical Ventures, and its PE ratio on FY26 profit 112.9 against 54.7.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
